Viewing Study NCT02794961


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT02794961
Status: UNKNOWN
Last Update Posted: 2016-06-09
First Post: 2016-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies
Sponsor: Kai Lin Xu; Jun Nian Zheng
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module